(Vienna, 19th March 2012) The European Breast Cancer Conference EBCC-8 will take place at the Austria Center Vienna from 21st to 23rd March 2012 and include more than 5,000 international experts from 90 countries, including several specialists from the Comprehensive Cancer Centre of the MedUni Vienna. On Saturday, 24th March 2012, 9 a.m. – 12 p.m., in the main building of the Technical University of Vienna (Prechtlsaal) as the closing event to the Conference a patients’ day is being held, which will introduce and discuss the latest findings of breast cancer research. Admission to this event is free.
Breast cancer is the most common cancer amongst women. 5,200 women contract the disease annually in Austria and 1,500 women die of it. Conference organiser Michael Gnant of MedUni Vienna's University department of Surgery states: “One of eight women will face this diagnosis once in their lifetime.“
The MedUni Vienna with the Comprehensive Cancer Centre (CCC) and die Austrian Breast & Colorectal Study Group (ABCSG) headed by Gnant enjoys an excellent international reputation in the field of breast cancer research and therapy. “For the conference to take place in Vienna, this is also a recognition of the work that Austria and in particular the Viennese colleagues have contributed to international breast cancer research in the past years“, says Nadia Harbeck, Head of the Breast Centre at the University of Munich.
The results of the Study 12 of the ABCSG received worldwide attention: Under the supervision of Gnant a research team successfully developed a new therapy for the early detection of breast cancer amongst young women. It was proven that the additional administration of the osteoporosis medication zoledronic acid during an anti-hormonal therapy statistically significantly reduced the relapse rate and levelled the therapy conditioned risk of bone reduction.
Top experts like the EBBC chairman David Cameron, Michael Gnant of the MedUni Vienna, the president of Europa Donna International, Elizabeth Bergsten Nordström, Paul Sevelda, president of the Austrian Cancer Charity, Thomas Helbich of the University Department of Radiodiagnostics of the MedUni Vienna and Miriam Strauss, president of Europa Donna Austria, will hold lectures during the Patients' Day. Says Gnant: “It is crucial that we present the results of top research to affected women in a generally understandable language. This is what will happen on 24th March. Furthermore there will be ample opportunity to ask the experts questions, who normally cannot be contacted that easily.“
Service: Saturday, 24th March, 9 a.m. – 12 p.m, Patients' Day in connection with the European Breast Cancer Conference at the Technical University of Vienna (main building, Prechtlsaal), Karlsplatz 13, 1040 Vienna. Admission is free.